Search results for "VOLUME"

showing 10 items of 1932 documents

Ambulatory Blood Pressure in Clinical Practice: Clinical Relevance of Circadian Rhythm and Nocturnal Dip

2012

Blood pressure (BP) variability and terms like dipper and nondipper are now common in daily practice. Several mechanisms underlie abnormalities in circadian variability. Sympathetic overactivity, reduced sensibility of baroreceptors, volume overload, and primary or secondary autonomic dysfunction are the most important factors related to abnormalities in circadian variability. The level of nighttime BP drop has been related to the absolute level of BP elevation, the global cardiovascular risk, the presence of comorbidities, and the type and time of administration of antihypertensive treatment. The relative importance of circadian variability or nocturnal BP as a prognostic factor raise not …

medicine.medical_specialtyAmbulatory blood pressureBaroreceptorbiologyDipperbusiness.industryVolume overloadNocturnalbiology.organism_classificationEndocrinologyBlood pressureInternal medicinemedicineCardiologyClinical significanceCircadian rhythmbusiness
researchProduct

SPLIT-LUNG VOLUMETRY IN PATIENTS AFTER SINGLE-LUNG TRANSPLANTATION USING 3HELIUM-MRI 

2000

medicine.medical_specialtyAnesthesiology and Pain Medicinebusiness.industryLung volumetrymedicineIn patientRadiologySingle Lung TransplantationbusinessAnesthesiology
researchProduct

Neprilysin inhibition, endorphin dynamics, and early symptomatic improvement in heart failure: a pilot study

2020

Altres ajuts: This work was supported in part by Fundació La Marató de TV3 (201516-10, 201502-30), Societat Catalana de Cardiologia, "la Caixa" Banking Foundation. Altres ajuts: PERIS/SLT002-16-00234 Sacubitril/valsartan is a first-in-class angiotensin receptor-neprilysin inhibitor developed for the treatment of heart failure with reduced ejection fraction. Its benefits are achieved through the inhibition of neprilysin (NEP) and the specific blockade of the angiotensin receptor AT1. The many peptides metabolized by NEP suggest multifaceted potential consequences of its inhibition. We sought to evaluate the short-term changes in serum endorphin (EP) values and their relation with patients' p…

medicine.medical_specialtyAngiotensin receptorEndorphins; Heart failure; Neprilysin; Sacubitril/valsartan; α-Endorphin; γ-Endorphinα‐EndorphinVascular damage Radboud Institute for Health Sciences [Radboudumc 16]HemodynamicsPilot ProjectsHeart failure030204 cardiovascular system & hematologyγ‐EndorphinvalsartanSacubitril03 medical and health sciences0302 clinical medicineOriginal Research ArticlesInternal medicinemedicineHumansDiseases of the circulatory (Cardiovascular) systemalpha-EndorphinOriginal Research ArticleProspective Studies030212 general & internal medicineSacubitril/valsartanγ-EndorphinAngiotensin II receptor type 1Ejection fractionbusiness.industryα-EndorphinStroke Volumegamma-Endorphinmedicine.diseaseSacubitrilValsartanRC666-701Heart failureCardiologyNeprilysinEndorphinsCardiology and Cardiovascular MedicinebusinessSacubitril Valsartanmedicine.drug
researchProduct

New insights into symptomatic or silent atrial fibrillation complicating acute myocardial infarction

2015

International audience; Atrial fibrillation (AF) is the most frequent heart rhythm disorder in the general population and contributes not only to a major deterioration in quality of life but also to an increase in cardiovascular morbimortality. The onset of AF in the acute phase of myocardial infarction (MI) is a major event that can jeopardize the prognosis of patients in the short-, medium- and long-term, and is a powerful predictor of a poor prognosis after MI. The suspected mechanism underlying the excess mortality is the drop in coronary flow linked to the acceleration and arrhythmic nature of the left ventricular contractions, which reduce the left ventricular ejection fraction. The p…

medicine.medical_specialtyAsymmetric dimethylarginineSurveillance ECG en continueAsymétrique diméthylargininePopulationMyocardial InfarctionInfarctus du myocardeAcute myocardial infarctionSudden deathContinuous ECG monitoringVentricular Function Left[SHS]Humanities and Social SciencesHeart RateRisk FactorsInternal medicineCoronary CirculationHeart rateAtrial FibrillationmedicinePronosticHumansMyocardial infarctionHospital MortalityeducationHeart FailureFibrillation atriale silencieuseeducation.field_of_studyEjection fractionbusiness.industryAtrial fibrillationStroke VolumeGeneral MedicineStroke volumemedicine.diseasePrognosisMyocardial ContractionOxidative StressSilent atrial fibrillationHeart failureAsymptomatic DiseasesCardiologyEndothelium Vascular[SHS] Humanities and Social SciencesbusinessCardiology and Cardiovascular Medicine
researchProduct

Forderungen und Erwartungen an einen optimalen Volumenersatz

2005

A volume replacement should compensate a reduction in the intravascular volume and counteract a hypovolemia so that hemodynamics and vital functions can be maintained. For this therapy, a physiologically-based solution comprising both osmotically and colloid osmotically active components should be administered. A consensus is proposed for this purpose which takes into consideration the following aspects: The optimum colloid, the questionable use of albumin, the physiological electrolyte pattern encompassing sodium, potassium, chloride and phosphate and their contributions to osmolality, an eventual addition of glucose, the physiological acid-base status with bicarbonate or alternately with …

medicine.medical_specialtyBicarbonateVolume replacementActive componentsBlood volumeGeneral MedicineElectrolyteCritical Care and Intensive Care MedicineSurgerychemistry.chemical_compoundAnesthesiology and Pain MedicinechemistryHypovolemiaEmergency MedicinemedicineIntravascular volume statusmedicine.symptomIntensive care medicineains · Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie
researchProduct

Prognostic impact of systolic blood pressure in acute heart failure with preserved ejection fraction in older patients

2021

Abstract Aims Recent guidelines recommend a systolic blood pressure (SBP) target below 130 mmHg in heart failure patients with preserved ejection fraction (HFpEF), whatever their age. We investigated whether this intensive SBP control was associated with better survival in very old adults hospitalized for acute HFpEF. Methods and results We conducted an observational study in an acute geriatric unit: all consecutive patients discharged from hospital for acute heart failure from 1 March 2019 to 29 February 2020 with a diagnosis of HFpEF were included. Re‐hospitalization and all‐cause mortality at 1 year were compared according to the mean SBP at discharge (patients with a mean SBP < 130 mmHg…

medicine.medical_specialtyBlood PressureVentricular Function LeftElderlyInternal medicineRe‐hospitalizationDiseases of the circulatory (Cardiovascular) systemHumansMedicineMortalityMedical prescriptionProspective cohort studyAgedAged 80 and overHeart FailureEjection fractionbusiness.industryHazard ratioStroke VolumeOriginal ArticlesPreserved ejection fractionPrognosismedicine.diseaseConfidence intervalBlood pressureRC666-701Heart failureSystolic blood pressureCardiologyOriginal ArticleCardiology and Cardiovascular MedicinebusinessHeart failure with preserved ejection fractionESC Heart Failure
researchProduct

EFSUMB Guidelines 2011: Comment on Emergent Indications and Visions

2012

The focus of this article is the emergent and potential indications of contrast-enhanced ultrasound (CEUS). Emergent applications of CEUS techniques include extravascular and intracavitary contrast-enhanced ultrasound, quantitative assessment of microvascular circulation for tumor response assessment, and tumor characterization using dynamic contrast-enhanced ultrasound (DCE-US). Potential indications for microbubble agents include novel molecular imaging and drug and gene delivery techniques, which have been successfully tested in animal models. "Comments and Illustrations of the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) Non-Liver Guidelines 2011" whi…

medicine.medical_specialtyBlood Volumebusiness.industryUltrasoundContrast MediaReproducibility of ResultsProgramming LinearImage EnhancementTumor responseSensitivity and SpecificityRegional Blood FlowImage Interpretation Computer-AssistedPractice Guidelines as TopicQuantitative assessmentHumansMedicineRadiology Nuclear Medicine and imagingMedical physicsRadiologybusinessSocieties MedicalSoftwareUltrasonographyUltraschall in der Medizin - European Journal of Ultrasound
researchProduct

Comparison of Arterial and Venous Blood Flow Between Patients with Pressure Dressing or a New Hemostatic Puncture Closure Device After Cardiac Cathet…

1997

The aim of the study was to compare arterial and venous flow volume in the punctured leg in patients given a conventional pressure dressing and those given a new hemostatic puncture closure device (Angio-Seal) after cardiac catheterization. We prospectively measured blood flow in 25 patients with pressure dressing (group A) and 25 patients with Angio-Seal (group B) after cardiac catheterization. Duplex sonographic measurements were performed at the superficial femoral artery and vein of the punctured leg. In group A measurements were performed before catheterization, during pressure dressing, and after removal of pressure dressing. In group B we performed the measurements before catheteriza…

medicine.medical_specialtyBlood flow volumebusiness.industrymedicine.medical_treatmentFemoral veinBlood flowFemoral arterySurgerymedicine.anatomical_structureAnesthesiamedicine.arteryVenous blood flowMedicineRadiology Nuclear Medicine and imagingIn patientCardiology and Cardiovascular MedicinebusinessVeinCardiac catheterizationJournal of Interventional Cardiology
researchProduct

The influence of dopamine on hemodynamics, microcirculation and renal function in patients with hypnotic drug intoxication

1976

The effect of dopamine on hemodynamics (CO, AoPm, TPR, SV, SW, CVP, PAPm, PAEDP), microcirculation (MBF, PS-product) and renal function (VU, CKI, CNa, CK, Cosm, TcH2O) was studied in 8 patients with hypnotic drug poisoning. With increasing doses of dopamine, cardiac output and heart rate increased and the peripheral resistance decreased. An augmentation of stroke volume and left ventricular stroke work was observed in the low dose range only (200--400 mug/min). With increasing doses, central venous pressure as well as mean pulmonary artery pressure and enddiastolic pulmonary artery pressure decreased. No vasoconstriction was found in muscle tissue vessels even with large doses of dopamine. …

medicine.medical_specialtyCardiac outputbusiness.industryCentral venous pressureHemodynamicsGeneral MedicineStroke volumeNorepinephrine (medication)Blood pressureDopamineShock (circulatory)Internal medicineDrug DiscoveryCardiologyMolecular MedicineMedicinemedicine.symptombusinessGenetics (clinical)medicine.drugKlinische Wochenschrift
researchProduct

Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without typ…

2020

Abstract Aims The EMPERIAL (Effect of EMPagliflozin on ExeRcise ability and HF symptoms In patients with chronic heArt faiLure) trials evaluated the effects of empagliflozin on exercise ability and patient-reported outcomes in heart failure (HF) with reduced and preserved ejection fraction (EF), with and without type 2 diabetes (T2D), reporting, for the first time, the effects of sodium-glucose co-transporter-2 inhibition in HF with preserved EF (HFpEF). Methods and results HF patients with reduced EF (HFrEF) (≤40%, N = 312, EMPERIAL-Reduced) or preserved EF (&amp;gt;40%, N = 315, EMPERIAL-Preserved), with and without T2D, were randomized to empagliflozin 10 mg or placebo for 12 weeks. The …

medicine.medical_specialtyCardiomyopathyType 2 diabetes030204 cardiovascular system & hematologyPlacebo03 medical and health sciences0302 clinical medicineGlucosidesInternal medicinemedicineClinical endpointEmpagliflozinHumans030212 general & internal medicineBenzhydryl CompoundsHeart FailureEjection fractionSurrogate endpointbusiness.industryStroke Volumemedicine.diseaseDiabetes Mellitus Type 2Heart failureCardiologyCardiology and Cardiovascular MedicinebusinessEuropean heart journal
researchProduct